chr11-55650930-A-T
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_001004059.3(OR4S2):c.27A>T(p.Glu9Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000174 in 1,439,770 control chromosomes in the GnomAD database, including 7 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001004059.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
OR4S2 | NM_001004059.3 | c.27A>T | p.Glu9Asp | missense_variant | 2/2 | ENST00000641692.1 | NP_001004059.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
OR4S2 | ENST00000641692.1 | c.27A>T | p.Glu9Asp | missense_variant | 2/2 | NM_001004059.3 | ENSP00000493389.1 |
Frequencies
GnomAD3 genomes AF: 0.00000722 AC: 1AN: 138424Hom.: 0 Cov.: 26
GnomAD3 exomes AF: 0.0000223 AC: 5AN: 223926Hom.: 2 AF XY: 0.0000329 AC XY: 4AN XY: 121506
GnomAD4 exome AF: 0.0000184 AC: 24AN: 1301346Hom.: 7 Cov.: 27 AF XY: 0.0000215 AC XY: 14AN XY: 649744
GnomAD4 genome AF: 0.00000722 AC: 1AN: 138424Hom.: 0 Cov.: 26 AF XY: 0.0000149 AC XY: 1AN XY: 67136
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 16, 2024 | The c.27A>T (p.E9D) alteration is located in exon 1 (coding exon 1) of the OR4S2 gene. This alteration results from a A to T substitution at nucleotide position 27, causing the glutamic acid (E) at amino acid position 9 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at